Talaris Therapeutics Price History

TALSDelisted Stock  USD 2.98  0.10  3.25%   
If you're considering investing in Talaris Stock, it is important to understand the factors that can impact its price. As of today, the current price of Talaris Therapeutics stands at 2.98, as last reported on the 19th of December, with the highest price reaching 3.08 and the lowest price hitting 2.98 during the day. We have found twenty-nine technical indicators for Talaris Therapeutics, which you can use to evaluate the volatility of the company. Please validate Talaris Therapeutics' Risk Adjusted Performance of 0.1022, coefficient of variation of 846.74, and Semi Deviation of 3.08 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Talaris Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
TALS
Based on monthly moving average Talaris Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Talaris Therapeutics by adding Talaris Therapeutics to a well-diversified portfolio.

Talaris Therapeutics Stock Price History Chart

There are several ways to analyze Talaris Stock price data. The simplest method is using a basic Talaris candlestick price chart, which shows Talaris Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Talaris Stock Price History Data

The price series of Talaris Therapeutics for the period between Fri, Sep 20, 2024 and Thu, Dec 19, 2024 has a statistical range of 1.02 with a coefficient of variation of 9.27. The price distribution for the period has arithmetic mean of 2.78. The median price for the last 90 days is 2.8. The company had dividends distributed to its stock-holders on 2023-10-19.
OpenHighLowCloseVolume
12/19/2024
 3.08  3.08  2.98  2.98 
07/24/2023 3.08  3.08  2.98  2.98  307,000 
07/21/2023 3.06  3.08  2.99  3.08  225,800 
07/20/2023 3.01  3.10  3.00  3.07  413,719 
07/19/2023 3.00  3.04  3.00  3.01  134,950 
07/18/2023 3.01  3.06  2.99  3.00  389,100 
07/17/2023 3.08  3.10  3.00  3.00  111,100 
07/14/2023 3.22  3.22  3.01  3.07  261,826 
07/13/2023 3.07  3.24  3.06  3.22  530,163 
07/12/2023 3.14  3.19  3.02  3.04  267,880 
07/11/2023 3.10  3.15  3.04  3.06  200,500 
07/10/2023 3.18  3.29  3.02  3.13  713,010 
07/07/2023 3.03  3.18  3.01  3.16  263,657 
07/06/2023 3.05  3.11  3.01  3.03  260,823 
07/05/2023 3.12  3.21  3.02  3.05  382,416 
07/03/2023 3.18  3.24  3.00  3.19  471,800 
06/30/2023 3.09  3.17  3.01  3.04  1,411,282 
06/29/2023 3.10  3.18  3.03  3.09  245,911 
06/28/2023 3.03  3.29  2.96  3.20  845,247 
06/27/2023 3.09  3.12  2.98  3.03  517,100 
06/26/2023 3.07  3.23  2.94  3.09  1,811,719 
06/23/2023 2.66  3.10  2.66  3.06  4,577,704 
06/22/2023 2.71  2.89  2.59  2.70  12,583,923 
06/21/2023 2.38  2.41  2.20  2.20  897,500 
06/20/2023 2.45  2.45  2.35  2.37  209,800 
06/16/2023 2.51  2.51  2.40  2.44  249,300 
06/15/2023 2.48  2.50  2.43  2.48  109,500 
06/14/2023 2.57  2.59  2.42  2.48  164,000 
06/13/2023 2.66  2.66  2.52  2.54  160,200 
06/12/2023 2.52  2.67  2.52  2.62  181,200 
06/09/2023 2.53  2.61  2.41  2.55  262,700 
06/08/2023 2.50  2.57  2.42  2.53  414,484 
06/07/2023 2.45  2.57  2.26  2.47  745,113 
06/06/2023 2.62  2.64  2.44  2.45  327,500 
06/05/2023 2.51  2.62  2.46  2.61  119,589 
06/02/2023 2.56  2.63  2.43  2.53  170,900 
06/01/2023 2.64  2.64  2.50  2.54  167,628 
05/31/2023 2.68  2.70  2.50  2.65  160,100 
05/30/2023 2.78  2.83  2.60  2.63  246,400 
05/26/2023 2.61  2.85  2.60  2.78  232,700 
05/25/2023 2.72  2.73  2.63  2.67  113,700 
05/24/2023 2.90  2.90  2.61  2.72  186,800 
05/23/2023 2.85  2.96  2.84  2.91  217,898 
05/22/2023 2.84  2.93  2.72  2.84  154,003 
05/19/2023 2.74  2.92  2.72  2.85  264,982 
05/18/2023 2.56  2.80  2.52  2.69  247,266 
05/17/2023 2.54  2.63  2.49  2.57  128,000 
05/16/2023 2.68  2.73  2.50  2.53  149,300 
05/15/2023 2.75  2.77  2.64  2.69  143,900 
05/12/2023 2.80  2.80  2.62  2.75  135,143 
05/11/2023 2.82  2.83  2.68  2.74  209,174 
05/10/2023 2.89  2.97  2.75  2.85  204,944 
05/09/2023 3.00  3.07  2.88  2.90  206,965 
05/08/2023 2.93  3.01  2.85  2.99  315,982 
05/05/2023 2.90  2.97  2.80  2.93  224,157 
05/04/2023 2.77  2.92  2.72  2.86  272,259 
05/03/2023 2.86  2.89  2.50  2.80  3,511,471 
05/02/2023 2.84  2.88  2.65  2.84  153,851 
05/01/2023 2.85  2.95  2.75  2.82  140,847 
04/28/2023 2.69  2.97  2.69  2.88  255,373 
04/27/2023 2.53  2.85  2.53  2.69  190,000 

About Talaris Therapeutics Stock history

Talaris Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Talaris is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Talaris Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Talaris Therapeutics stock prices may prove useful in developing a viable investing in Talaris Therapeutics
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. Talaris Therapeutics, Inc. was founded in 1988 and is headquartered in Louisville, Kentucky. Talaris Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 128 people.

Talaris Therapeutics Stock Technical Analysis

Talaris Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Talaris Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Talaris Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Crypto Correlations Now

   

Crypto Correlations

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
All  Next Launch Module

Talaris Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Talaris Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Talaris Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Talaris to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Consideration for investing in Talaris Stock

If you are still planning to invest in Talaris Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talaris Therapeutics' history and understand the potential risks before investing.
Global Correlations
Find global opportunities by holding instruments from different markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Share Portfolio
Track or share privately all of your investments from the convenience of any device